Phase I Study Of Fluzoparib, A Parp1 Inhibitor In Combination With Apatinib And Paclitaxel In Patients (Pts) With Advanced Gastric And Gastroesophageal Junction (Gej) Adenocarcinoma.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要